> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# House Urges Senate to Pass User Fee Reauthorization
- URL: https://www.fdaweb.com/house-urges-senate-to-pass-user-fee-reauthorization/
- Published: 2022-07-14T12:00:00.000Z
- Updated: 2026-09-14T17:52:02.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5152284

The House Energy and Commerce Committee leadership is urging the Senate to “urgently” reauthorize FDA’s user fee programs. “Unless the Senate acts urgently to meet its deadline, FDA will be forced to issue reduction-in-force notices and furlough thousands of workers who ensure the safety and efficacy of medical products,” committee chairman **Frank Pallone**, **Jr.** (D-NJ) and ranking member **Cathy McMorris Rodgers** (R-WA) said in a 7/14 statement.

“Any delay is unacceptable, especially after the House passed the bipartisan Food and Drug Amendments of 2022 more than five weeks ago by an overwhelming vote of 392-28,” the Committee leaders said while urging the Senate chamber to bring the House version of the user fee package to a floor for a vote before August. “There is no reason for the Senate to reject the strongest and best path forward to ensure this reaches the president’s desk. For patients, it means lower health care costs, stronger supply chains, critical access to lifesaving prescription drugs, and more hope in the promise for new cures and treatments that will improve their quality of life.”

Earlier this week, FDA commissioner **Robert Califf** told the Alliance for a Stronger FDA that the uncertainty around the reauthorization hurts the agency’s staff recruitment and retention efforts. “Who wants to work in an organization if you’re afraid that these jobs are not even going to exist in the next short period of time?” he asked. “We really need to avoid that… If user fees are not funded, we’ll review products as quickly as we can, but the timelines go away and the commitment to the timelines goes away.”